India consults on national policy to promote, protect local medical device industry
This article was originally published in SRA
The Indian government is inviting feedback on its first ever national-level policy on medical devices that aims to support the domestic medtech industry through a variety of measures, such as by creating a separate National Medical Device Authority (NMDA), changing the tax/duty structure to promote and protect local device companies, and creating a separate regulator for medtech pricing issues1.
You may also be interested in...
India will finally get a device-specific regulatory framework when new rules formed by the government come into force next year. While the medtech industry has welcomed this long-awaited development, it hopes that its outstanding concerns will be addressed before the rules come into play.
The UK regulator is expecting a rise in amendments and deviations to ongoing clinical investigations of medical devices due to the COVID-19 pandemic and has issued advice on how companies should manage these.
Work and movement-related restrictions are affecting the ability of companies to provide a timely response to questions relating to their prequalification dossiers.